Fisher Asset Management Portfolio holdings
Fisher Asset Management, LLC, operating as Fisher Investments, was founded in 1979 by Ken Fisher and is headquartered in Plano, Texas, following a relocation from Camas, Washington, in 2023. As an independent, fee-only investment adviser, it manages over $275 billion in assets for individual and institutional investors globally as of June 2024, offering tailored portfolio management through its Private Client Group and Institutional Group. Known for its active, top-down investment approach guided by a five-member Investment Policy Committee, the firm emphasizes asset allocation and has expanded internationally with offices in eight countries, including a wholly owned subsidiary, Fisher Investments Europe Limited, in London. With Ken Fisher as executive chairman and co-chief investment officer, succeeded as CEO by Damian Ornani in 2016, Fisher Investments blends a legacy of innovation with a client-first philosophy, recently spinning off its 401(k) Solutions into Fisher Retirement Solutions in 2024.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$3.63B |
| 2 |
GE Aerospace
GE
|
+$3.62B |
| 3 |
Cisco
CSCO
|
+$1.68B |
| 4 |
UnitedHealth
UNH
|
+$1.42B |
| 5 |
Merck
MRK
|
+$1.41B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$1.97B |
| 2 |
ConocoPhillips
COP
|
+$1.69B |
| 3 |
ING
ING
|
+$1.3B |
| 4 |
Chevron
CVX
|
+$973M |
| 5 |
Johnson Controls International
JCI
|
+$954M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.63% |
| 2 | Financials | 16.68% |
| 3 | Industrials | 13.38% |
| 4 | Miscellaneous | 10.91% |
| 5 | Healthcare | 10.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
iShares ESG Aware MSCI USA ETF
ESGU
$18.3B
| $11.1M | ﹤0.01% |
67,897
+2,934
| +5% | +$464K |
|
402
Ionis Pharmaceuticals
IONS
$10.1B
| $10.9M | ﹤0.01% |
137,184
-4,360
| -3% | -$328K |
|
|
XHR
403
Xenia Hotels & Resorts
XHR
$1.8B
| $10.7M | ﹤0.01% |
527,861
+128,196
| +32% | +$2.21M |
|
404
Vanguard Morningstar Total Stock Market ETF
VTI
$687B
| $10.7M | ﹤0.01% |
29,001
+7,699
| +36% | +$2.75M |
|
405
Exelixis
EXEL
$13.5B
| $10.6M | ﹤0.01% |
195,661
+30,712
| +19% | +$1.5M |
|
406
iShares Core MSCI Europe ETF
IEUR
$9.41B
| $10.5M | ﹤0.01% |
139,408
-32,730
| -19% | -$2.44M |
|
407
Vanguard Long-Term Treasury ETF
VGLT
$10.4B
| $10.3M | ﹤0.01% |
187,414
-15,545
| -8% | -$853K |
|
408
Krystal Biotech
KRYS
$10.4B
| $10.3M | ﹤0.01% |
27,676
-108
| -0.4% | -$32.3K |
|
409
Pebblebrook Hotel Trust
PEB
$2.09B
| $10.3M | ﹤0.01% |
529,861
-26,342
| -5% | -$406K |
|
410
First Interstate BancSystem
FIBK
$3.53B
| $10.2M | ﹤0.01% |
265,538
-419
| -0.2% | -$14.8K |
|
411
ResMed
RMD
$34.7B
| $10.2M | ﹤0.01% |
52,511
-1,595
| -3% | -$331K |
|
412
Domino's
DPZ
$11.6B
| $10M | ﹤0.01% |
33,799
-682
| -2% | -$224K |
|
413
Bristol-Myers Squibb
BMY
$136B
| $9.99M | ﹤0.01% |
173,404
-30,250
| -15% | -$1.74M |
|
414
PNC Financial Services
PNC
$96.6B
| $9.69M | ﹤0.01% |
39,340
+33,080
| +528% | +$7.41M |
|
415
Service Corp International
SCI
$11.4B
| $9.66M | ﹤0.01% |
127,119
+26
| +0% | +$2.03K |
|
416
Mirum Pharmaceuticals
MIRM
$5.94B
| $9.66M | ﹤0.01% |
82,476
-10,633
| -11% | -$1.07M |
|
417
Altria Group
MO
$115B
| $9.65M | ﹤0.01% |
134,120
+8,575
| +7% | +$599K |
|
418
CVS Health
CVS
$119B
| $9.52M | ﹤0.01% |
92,010
+3,618
| +4% | +$323K |
|
419
STAG Industrial
STAG
$7.17B
| $9.5M | ﹤0.01% |
249,494
+58,562
| +31% | +$2.24M |
|
420
First Industrial Realty Trust
FR
$8.21B
| $9.42M | ﹤0.01% |
153,681
+35,087
| +30% | +$2.17M |
|
421
The Greenbrier Companies
GBX
$1.42B
| $9.38M | ﹤0.01% |
191,402
-12,109
| -6% | -$595K |
|
422
Medtronic
MDT
$117B
| $9.16M | ﹤0.01% |
117,104
-22,235
| -16% | -$1.79M |
|
423
Nurix Therapeutics
NRIX
$2.72B
| $8.96M | ﹤0.01% |
369,465
-15,366
| -4% | -$262K |
|
424
Monte Rosa Therapeutics
GLUE
$1.14B
| $8.8M | ﹤0.01% |
363,520
+48,658
| +15% | +$919K |
|
425
Rayonier
RYN
$6.06B
| $8.74M | ﹤0.01% |
410,879
-10,762
| -3% | -$225K |
|
Similar funds
Fisher Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Fisher Asset Management held 1,138 positions worth $336B, up 14% from $295B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Fisher Asset Management's Q2 2026 filing shows 122 new, 384 increased, 501 reduced and 101 closed positions. Its largest new stake was Honeywell Aerospace: 74,226 shares worth $16.4M. The largest sale was Canadian Natural Resources, an estimated $1.97B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.
- Fisher Asset Management's largest Q2 2026 buy was Honeywell Aerospace: 74,226 shares worth $16.4M.
- Fisher Asset Management added most to GE Vernova in Q2 2026, an estimated $3.63B increase.
- Fisher Asset Management's biggest Q2 2026 reduction was Canadian Natural Resources, cutting an estimated $1.97B.
- Fisher Asset Management fully exited Arcosa in Q2 2026, selling an estimated $11.1M.
- Fisher Asset Management's ten largest holdings make up 36% of its $336B portfolio in Q2 2026.
- Fisher Asset Management opened 122 new positions and closed 101 in Q2 2026.
- Fisher Asset Management's portfolio value rose 14% quarter-over-quarter to $336B.
Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.